Pharmacopoeia standards for medications used in Ayurveda, Siddha, Unani, and homoeopathy will shortly be developed by PCIM&H.

The Pharmacopoeia Commission of Indian Medicine and Homoeopathy (PCIM&H) may soon start developing pharmacopoeia standards for the Ayurvedic, Siddha, Unani, and Homoeopathic medications under the “One Herb One Standard” (OHOS) among other projects during the budget year 2023–2024. According to…

Walk-in Interview for Medical Device Department at WIPRO – B. Pharma/ M. Pharma/ Life science/ Fresher/ Experienced

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) is a leading technology services and consulting company focused on building innovative solutions that address clients’ most complex digital transformation needs. We leverage our holistic portfolio of capabilities in consulting, design, engineering,…

The Delhi High Court rejects Boehringer Ingelheim’s request for a temporary restraining order, and generic linagliptin production is permitted.

In a patent dispute involving the former’s diabetes drug linagliptin, a single judge of the Delhi High Court declined to grant an interim injunction in favour of German pharmaceutical giant Boehringer Ingelheim against Indian generic manufacturers, noting that the patent…

Back to top

Registration Form


This will close in 0 seconds

WhatsApp Join Telegram